Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial
Go back to Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial| TIBCO Software, Inc. (NYSE: IBX) | Delayed: 17.81 +0.03 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.78 | 52 Week High | $0.90 | |||
| Open | $17.64 | 52 Week Low | $0.48 | |||
| Day High | $18.00 | P/E | 80.95 | |||
| Day Low | $17.35 | EPS | $0.22 | |||
| Volume | 160,198 | |||||
